Cetuximab in combination with capecitabine, irinotecan, and radiotherapy for patients with locally advanced rectal cancer: results of a Phase II MARGIT trial. (Q46170948)
Jump to navigation
Jump to search
scientific article published on 7 January 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Cetuximab in combination with capecitabine, irinotecan, and radiotherapy for patients with locally advanced rectal cancer: results of a Phase II MARGIT trial. |
scientific article published on 7 January 2009 |
Statements
Cetuximab in combination with capecitabine, irinotecan, and radiotherapy for patients with locally advanced rectal cancer: results of a Phase II MARGIT trial (English)
Karoline Horisberger
Anne Treschl
Sabine Mai
Peter Kienle
Philipp Ströbel
Philipp Erben
Christoph Woernle
Dietmar Dinter
Georg Kähler
Stefan Post
Frank Willeke
Frederik Wenz
Ralf-Dieter Hofheinz
MARGIT (Mannheimer Arbeitsgruppe für Gastrointestinale Tumoren)